STADA’s Bold Bets on M&A
After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness to make bold bets on areas including…
Tagged with Company Spotlight
Alvotech’s Four Traits for Biosimilars Success
Alvotech – the biosimilars arm of Icelandic-headquartered generics player Alvogen – is positioning itself for future growth via a very different…
Japan’s Taiho Pharmaceutical: An Oral Chemotherapy Pioneer
Japanese pharma companies are already far lower-profile than their occidental counterparts but an even lesser-known player may be Taiho…
Novartis Oncology US: Leaning into Change
With a series of reorganization initiatives, new leaders at the helm and exciting acquisitions, Novartis Oncology has undergone a significant business…
Eisai Targeting Global Leadership in Neurology & Oncology…
Founded by Toyoji Naito in December 1941, in just under 80 years, Eisai has become a leading global biopharma player, with pharmaceutical revenues of…
Four Cell & Gene Companies to Know in China
While cell and gene therapies are all the rage now, a little known fact is that the world’s first approved gene therapy actually came from a Chinese…
Abdi Ibrahim Buys 28.5% Stake in Swiss OM; A Historic Moment for…
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a historic moment for Turkey's pharma…
Edigene CEO on Gene Editing Biotech’s Ambitious Expansion Plans
Following a recent capital injection of USD 67 million, Chinese biotech EdiGene is set to advance its pipeline in gene editing treatments and…
The German Biotech Behind Pfizer’s COVID-19 Vaccine Candidate
German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant Pfizer on a COVID-19 vaccine. The…
How Chugai Became Japan’s Top Pharma Company
In 2020, Chugai Pharmaceutical Co. became Japan’s biggest drug company, driven by strong performance in recent years both from the company’s own…
Five Norwegian Medtechs to Watch
Norway, known more for its expertise in oil and gas and marine biology than in health innovation, is home to increasing numbers of innovative medical…
Biotech Spotlight: Alphamab Oncology, China
Founded in 2009 by CEO Dr XU Ting, Alphamab started its journey as a protein engineering company with the ultimate dream of becoming, as many Chinese…
